Clicks Group Ltd (CLCGY) fair value: what the stock is really worth
We calculate from audited financials what Clicks Group Ltd is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily, free.
Compare price with fair valuebelow fair value = cheap, above = expensive
Check the quality50 and up solid, 75 and up strong
Watch it or check another stockalert when fair value or trend changes
Healthcare · US · Market cap $3.3B · ISIN US18682W2052
At a glance
CGClicks Group LtdCLCGY · US
Price$24.53
Fair Value$35.03
Upside+42.8%
Quality74/100
A solid business, trading 30% below our fair value of $35.03.
As of Aug 29, 2026, the fair value of Clicks Group Ltd is $35.03 per share against a price of $24.53, so the fair value sits 43% above the price. A model estimate from reported figures, not an analyst target.
✓Healthy Growth (revenue 5y +7.8 %/yr)
!Thin margins · 6.7% net margin
✓Low debt · generates free cash flow
·3.70% dividend yield
✓Ranks above peers (11/11)
!Moderate moat 63/100
!Evidence only medium, so the estimate is less certain
Evidence: MediumRange $26.27 to $43.78
Fair value as of: Aug 29, 2026
From 26 valuation models · updated 11 days ago
Fair value updated Aug 29, 2026, revised from $35.14 to $35.03 (−0.3%) since Aug 13, 2026. Share price −8.5% over the past month.
This is the short version. In the app for Clicks Group Ltd:
Watch Clicks Group Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for free
69 individual criteria per stock, every one traceable See the method →
What matters now
The rarer combination: high quality (74/100) AND below fair value. That earns a closer look rather than a quick verdict.
The price is below even our cautious bear case ($26.27). The market is more pessimistic than our downside scenario.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 29, 2026.
How to read this chart
60‑month range $22.01 – $44.57 · fair‑value band $26.27 – $43.78 · the $24.53 price screens below the $35.03 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 29, 2026.
Clicks Group Ltd (CLCGY) currently trades at $24.53, while our model-based Fair Value estimate is $35.03, implying the stock looks roughly 30.0% undervalued today. The Quality Score stands at 74/100 (solid quality), in the Healthcare sector. Bull case: the Earnings-Based group reads highest at a median of $246.68 per share, and 26 of the 26 models we run sit above the $24.53 price. Bear case: the Asset-Based group reads lowest at $39.17, and 0 of the 26 models stay below the price. Evidence for this calculation is medium.
Over the trailing twelve months, Clicks Group Ltd generated revenue of $49.5B at a net margin of 6.7%. Revenue grew 7.4% year over year. It earns a return on equity of 53.3%. Net debt stands at $3.5B. Fundamentals as of Aug 29, 2026
Scenario range: $26.27 (bear) to $43.78 (bull), the price of $24.53 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target. The share trades about 43% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −23% fair-value upside, at 43%, CLCGY screens cheaper than that median.
Fair Value models
Each model values the company its own way; the fair value above is the evidence-weighted blend. Evidence (0 to 100) shows how complete a model's inputs are. How we calculate →
ModelBear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence
Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
P/E ratio14.0
P/S ratio0.88P/E × margin
EPS (TTM)$1.75price ÷ EPS = P/E 14.0
Dividend yield3.7%payout 51.9%
Net margin6.3%FY2025
Return on equity53.3%TTM
More key figures
Profitability
Return on assets (EBIT)19.3%avg 5y
Operating margin9.1%TTM
Growth
Revenue (TTM)$49.5BTTM
Revenue growth (YoY)+7.4%3y avg +8.1%
EPS growth (YoY)+8.3%
Balance sheet & cash flow
Free cash flow$4.2BFY2025
Net debt$3.5BFY2025 · ≈ 0.8 yrs of FCF
Figures from reported company fundamentals · as of Aug 29, 2026. TTM = trailing twelve months.
Quality Score breakdown
Overall quality74/100
Of which business quality 73
· Market factors (momentum, volatility) 29
Profitability83
Margins and returns on capital today
Quality Growth58
Are margins and returns improving?
Cashflow60
Earnings quality: real cash, not paper profit
Fin. Strength74
Balance sheet, leverage, solvency risk
Investment76
Disciplined investing over empire-building
Low Volatility83
Calm price path (market factor)
Momentum11
Price trend over the last 3–12 months (market factor)
52W Momentum0
Distance to the 52-week high (market factor)
Net Issuance86
Buybacks instead of dilution
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Clicks Group Limited, together with its subsidiaries, operates as a health, wellness, and beauty retailer in South Africa and internationally. The company operates through two segments, Retail and Distribution.
Full company description
Clicks Group Limited, together with its subsidiaries, operates as a health, wellness, and beauty retailer in South Africa and internationally. The company operates through two segments, Retail and Distribution. It provides retail, including Clicks, a specialist health, beauty and homeware retailer; Sorbet, a franchise of hair and beauty salons; 180 Degrees Marketing, a software development company; and The Body shop, which specializes in naturally inspired luxury toiletries, cosmetics, gifting and grooming, with stores. The company also offers various ranges of mother-and-baby products, including baby hardware, accessories, health, food, diaper and wipes, and baby toiletries under the Clicks Baby brand; and diabetic clinic, travel clinic, and wound management practice under the M-KEM brand. In addition, the company is involved in the wholesale and supply of pharmaceutical products to retail pharmacies, private hospitals, dispensing doctors, and retail health stores under the UPD brand. The company was formerly known as New Clicks Holdings Limited and changed its name to Clicks Group Limited in June 2009. Clicks Group Limited was founded in 1968 and is headquartered in Cape Town, South Africa.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Clicks Group Ltd reported revenue of 50.0B ZAR in FY2025 versus 37.3B ZAR in FY2021, a compound +7.6%/yr. Reported net income was 3.2B ZAR in FY2025, compounding +14.5%/yr from FY2021.
Growth Quality 81/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
$50.0B
Latest YoY
+10.1%
Avg. revenue growth/yr (3Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.1%
Avg. revenue growth/yr (5Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+7.8%
Avg. revenue growth/yr (23Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.1%
Value creation/yr (5Y, in ZAR) ⓘEarnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year. Measured in ZAR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+16.0%
Earnings growth per share plus dividend yield: the value created per share and year.
Earnings growth per share+12.3%
Dividend yield3.7%
Trend ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5Y 12.3% vs 10Y 13.3%, steady
Operating margin (EBIT) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.8.1% (2020) → 9.1% (2025) · steady
Revenue+7.6%/yr
FY2137.3B ZAR
FY2239.6B ZAR
FY2341.6B ZAR
FY2445.4B ZAR
FY2550.0B ZAR
Net income+14.5%/yr
FY211.8B ZAR
FY222.6B ZAR
FY232.5B ZAR
FY242.8B ZAR
FY253.2B ZAR
Character of growth · EPS growth decomposed (2014-2025)+13.2 % p.a.
Revenue per share+9.1 %
of which total revenue +8.6 % · buybacks/dilution +0.5 %
EBIT margin+3.9 %
Tax rate+0.2 %
Residual (interest, one-offs)−0.3 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
This stockSector peers
VALUE90· sector 21
FUTURE37· sector 21
PAST100· sector 15
HEALTH100· sector 98
DIVIDEND74· sector 62
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate (as of Aug 29, 2026).
Is Clicks Group Ltd (CLCGY) overvalued or undervalued?
As of Aug 29, 2026, our model estimates a fair value of $35.03 versus a price of $24.53, about +43% upside (undervalued).
What is the fair value of CLCGY?
Our model-based fair value for Clicks Group Ltd is $35.03 (as of Aug 29, 2026), built from audited fundamentals. The current price: $24.53.
What is the quality score of CLCGY?
Clicks Group Ltd has a Quality Score of 74/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Clicks Group Ltd (CLCGY)?
Our model-based price target is the fair value of $35.03 (as of Aug 29, 2026) from 26 valuation models. Cautious scenario $26.27, optimistic scenario $43.78. It is a calculation from audited fundamentals, not an analyst target.
What is the Clicks Group Ltd stock forecast for 2026?
Our models put fair value at $35.03, about +43% upside versus a price of $24.53 (undervalued). Cautious scenario $26.27, optimistic scenario $43.78. The calculation is refreshed regularly with new filings.
What is the revenue of Clicks Group Ltd (CLCGY)?
Clicks Group Ltd reported trailing-twelve-month revenue of about $49.5B (latest available figure, as of Aug 29, 2026).
What is the net profit margin of CLCGY?
The net profit margin of Clicks Group Ltd is about 6.7%, meaning it keeps roughly 6.7% of revenue as net income. Based on the latest reported figures.
Does Clicks Group Ltd pay a dividend?
Clicks Group Ltd currently shows a dividend yield of about 3.70% relative to its recent price (as of Aug 29, 2026).
What is the intrinsic value of Clicks Group Ltd (CLCGY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Clicks Group Ltd it is $35.03 per share (as of Aug 29, 2026), against a price of $24.53. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Clicks Group Ltd stock overvalued or undervalued in 2026?
As of Aug 29, 2026, CLCGY trades below its calculated fair value: price $24.53, fair value $35.03, a gap of about +43% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CLCGY?
No. The price is what the market pays today ($24.53); the fair value is what the company's own numbers justify ($35.03). For Clicks Group Ltd the two are $10.50 per share apart. That gap is exactly why we show both numbers side by side.
How much is Clicks Group Ltd worth?
The market values Clicks Group Ltd at about $3.3B (market capitalisation, as of Aug 29, 2026). Per share that is $24.53; our models calculate a fair value of $35.03 per share.
What do the bullish and bearish scenarios say about CLCGY?
Our models span a range for Clicks Group Ltd: cautious scenario $26.27, base $35.03, optimistic $43.78 per share (as of Aug 29, 2026, price $24.53). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CLCGY?
Clicks Group Ltd trades at a price-to-earnings ratio of 14.0 (as of Aug 29, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $35.03 is built from several models across several years.
How solid is the balance sheet of Clicks Group Ltd (CLCGY)?
Balance-sheet figures for Clicks Group Ltd (as of Aug 29, 2026): return on equity 53.3%. They feed the Quality Score of 74/100, which measures business quality independently of the share price.
How far is CLCGY from its 52-week high?
Clicks Group Ltd trades at $24.53, about 43% below its 52-week high of $43.37 (as of Aug 29, 2026). Distance from the high says nothing about value: that is what the fair value of $35.03 is for.
Which stocks are comparable to Clicks Group Ltd?
From the same area (Healthcare) we also value JD Health International Inc, Alibaba Health Information Technology Limited, Yifeng Pharmacy Chain Co, DaShenLin Pharmaceutical Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Clicks Group Ltd stock attractive at the current price?
The data as of Aug 29, 2026: price $24.53, calculated fair value $35.03 (+43%), Quality Score 74/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CLCGY calculated?
We run Clicks Group Ltd through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $35.03, with the spread shown as a cautious and an optimistic scenario.
Free · no account needed
Watch Clicks Group Ltd in the live analysis
One click puts Clicks Group Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Clicks Group Ltd
CLCGY · US